Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicentre, Parallel-group, Phase II, Randomised, Double-blind, 4 Arm Study to Evaluate Efficacy and Safety of AZD1163 in Participants With Moderately-to-Severely Active Rheumatoid Arthritis (LaunchPAD-RA)

NCT07276581 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT07276581
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07276581 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicentre, Parallel-group, Phase II, Randomised, Double-blind, 4 Arm Study to Evaluate Efficacy and Safety of AZD1163 in Participants With Moderately-to-Severely Active Rheumatoid Arthritis (LaunchPAD-RA)
Lead sponsor
AstraZeneca
Phase
Phase 2
Overall status
Recruiting
Start date
December 15, 2025
Completion date
August 18, 2028
Enrollment
320 (estimated)
Sites
147

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis